1.

Preferred prenatal counselling at the limits of viability:a survey among Dutch perinatal professionals

2.

Preferred prenatal counselling at the limits of viability:a survey among Dutch perinatal professionals

3.

Preferred prenatal counselling at the limits of viability:a survey among Dutch perinatal professionals

4.

Preferred prenatal counselling at the limits of viability:a survey among Dutch perinatal professionals

5.

Preferred prenatal counselling at the limits of viability:a survey among Dutch perinatal professionals

6.

Preferred prenatal counselling at the limits of viability:a survey among Dutch perinatal professionals

7.

Preferred prenatal counselling at the limits of viability:a survey among Dutch perinatal professionals

8.

Preferred prenatal counselling at the limits of viability:a survey among Dutch perinatal professionals

9.

Preferred prenatal counselling at the limits of viability:a survey among Dutch perinatal professionals

1.

A combined linkage, microarray and exome analysis suggests MAP3K11 as a candidate gene for left ventricular hypertrophy

2.

A combined linkage, microarray and exome analysis suggests MAP3K11 as a candidate gene for left ventricular hypertrophy

3.

A combined linkage, microarray and exome analysis suggests MAP3K11 as a candidate gene for left ventricular hypertrophy

4.

A combined linkage, microarray and exome analysis suggests MAP3K11 as a candidate gene for left ventricular hypertrophy

5.

A combined linkage, microarray and exome analysis suggests MAP3K11 as a candidate gene for left ventricular hypertrophy

6.

A combined linkage, microarray and exome analysis suggests MAP3K11 as a candidate gene for left ventricular hypertrophy

7.

A combined linkage, microarray and exome analysis suggests MAP3K11 as a candidate gene for left ventricular hypertrophy

8.

A combined linkage, microarray and exome analysis suggests MAP3K11 as a candidate gene for left ventricular hypertrophy

9.

A combined linkage, microarray and exome analysis suggests MAP3K11 as a candidate gene for left ventricular hypertrophy

1.

Skin cancer screening campaign in the German speaking Community of Belgium.

2.

Skin cancer screening campaign in the German speaking Community of Belgium.

3.

Skin cancer screening campaign in the German speaking Community of Belgium.

4.

Skin cancer screening campaign in the German speaking Community of Belgium.

5.

Skin cancer screening campaign in the German speaking Community of Belgium.

6.

Skin cancer screening campaign in the German speaking Community of Belgium.

7.

Skin cancer screening campaign in the German speaking Community of Belgium.

8.

Skin cancer screening campaign in the German speaking Community of Belgium.

9.

Skin cancer screening campaign in the German speaking Community of Belgium.

1.

Worship with Children:agentive participation in Dutch Protestant contexts

2.

Worship with Children:agentive participation in Dutch Protestant contexts

3.

Worship with Children:agentive participation in Dutch Protestant contexts

4.

Worship with Children:agentive participation in Dutch Protestant contexts

5.

Worship with Children:agentive participation in Dutch Protestant contexts

6.

Worship with Children:agentive participation in Dutch Protestant contexts

7.

Worship with Children:agentive participation in Dutch Protestant contexts

8.

Worship with Children:agentive participation in Dutch Protestant contexts

9.

Worship with Children:agentive participation in Dutch Protestant contexts

1.

Oral contraceptives and the dexamethasone suppression test

2.

Oral contraceptives and the dexamethasone suppression test

3.

Oral contraceptives and the dexamethasone suppression test

4.

Oral contraceptives and the dexamethasone suppression test

1.

Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases

2.

Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases

3.

Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases

4.

Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases

1.

Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands:Clinical and Economic Effects

2.

Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands:Clinical and Economic Effects

3.

Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands:Clinical and Economic Effects

4.

Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands:Clinical and Economic Effects

1.

Explaining educational inequalities in birthweight: The Generation R Study

2.

Explaining educational inequalities in birthweight: The Generation R Study

1.

Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: What to prescribe in daily clinical practice?

2.

Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: What to prescribe in daily clinical practice?

3.

Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: What to prescribe in daily clinical practice?

4.

Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: What to prescribe in daily clinical practice?

1.

Performance of population specific job exposure matrices (JEMs): European collaborative analyses on occupational risk factors for chronic obstructive pulmonary disease with job exp...

2.

Performance of population specific job exposure matrices (JEMs): European collaborative analyses on occupational risk factors for chronic obstructive pulmonary disease with job exp...

3.

Performance of population specific job exposure matrices (JEMs): European collaborative analyses on occupational risk factors for chronic obstructive pulmonary disease with job exp...

4.

Performance of population specific job exposure matrices (JEMs): European collaborative analyses on occupational risk factors for chronic obstructive pulmonary disease with job exp...

5.

Performance of population specific job exposure matrices (JEMs): European collaborative analyses on occupational risk factors for chronic obstructive pulmonary disease with job exp...

6.

Performance of population specific job exposure matrices (JEMs): European collaborative analyses on occupational risk factors for chronic obstructive pulmonary disease with job exp...

7.

Performance of population specific job exposure matrices (JEMs): European collaborative analyses on occupational risk factors for chronic obstructive pulmonary disease with job exp...

8.

Performance of population specific job exposure matrices (JEMs): European collaborative analyses on occupational risk factors for chronic obstructive pulmonary disease with job exp...

9.

Performance of population specific job exposure matrices (JEMs): European collaborative analyses on occupational risk factors for chronic obstructive pulmonary disease with job exp...